Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART

ClinicalTrials.gov ID: NCT00035581

Public ClinicalTrials.gov record NCT00035581. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Controlled Study of the Biological Actions of Ampligen as an Adjunct to HAART in HIV Disease

Study identification

NCT ID
NCT00035581
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
AIM ImmunoTech Inc.
Industry
Enrollment
16 participants

Conditions and interventions

Interventions

  • poly I-poly C12U Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2001
Primary completion
Aug 31, 2005
Completion
Aug 31, 2005
Last update posted
Apr 16, 2013

2001 – 2005

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
7
Facility City State ZIP Site status
Orange County Center for Special Immunology Fountain Valley California 92708
Circle Medical Center Norwalk Connecticut 06851
Dupont Circle Physicians Group Washington D.C. District of Columbia 20009
Julia Torres, MD Fort Lauderdale Florida 33306
Scott Ubillos, MD Tampa Florida 33607
St. Michael's Medical Center Newark New Jersey 07102
W. Chris Woodward, DO Reading Pennsylvania 19601

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00035581, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2013 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00035581 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →